Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in youngsters and individuals. In Canada, its distribution is managed by Health https://teva-lisdexamfetamine-in749542.blogcheer.com/554867/this-medication-in-canada-a-complete-guide